ADVANCED CERVICAL CARCINOMA
Clinical trials for ADVANCED CERVICAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED CERVICAL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED CERVICAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-phase study tests a new drug called BAY 1895344 combined with standard chemotherapy (cisplatin, with or without gemcitabine) in people with advanced solid tumors, especially bladder cancer. The main goals are to find the safest dose and understand side effects. About 7…
Matched conditions: ADVANCED CERVICAL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 09:53 UTC
-
New drug combo shows promise against tough cervical cancer
Disease control OngoingThis study tests whether combining two drugs, dostarlimab and cobolimab, can shrink tumors or slow the disease in people with advanced or recurrent cervical cancer. About 66 participants with measurable tumors will receive the combination. The main goal is to see how many patient…
Matched conditions: ADVANCED CERVICAL CARCINOMA
Phase: PHASE2 • Sponsor: Meghan Shea • Aim: Disease control
Last updated May 18, 2026 12:11 UTC